cough

Bayer’s eliapixant hits the right notes in PAGANINI cough study

https://pharmaphorum.com/news/bayers-eliapixant-hits-the-right-notes-in-paganini-cough-study/

Chasing Merck & Co, Bayer builds case for cough drug eliapixant

https://pharmaphorum.com/news/chasing-merck-bayer-builds-case-for-cough-drug-eliapixant/

COVID cough app Hyfe launches in UK and Ireland

https://pharmaphorum.com/news/covid-cough-app-hyfe-launches-in-uk-and-ireland/

Does my cough sound like COVID? There could be an app for that

https://pharmaphorum.com/news/does-my-cough-sound-like-covid-there-could-be-an-app-for-that/

Merck & Co plans to file cough drug gefapixant after phase 3 success

https://pharmaphorum.com/news/merck-co-plans-to-file-cough-drug-gefapixant-after-phase-3-success/

Merck’s chronic cough drug gefapixant clears phase 3 test

https://pharmaphorum.com/news/mercks-chronic-cough-drug-gefapixant-clears-phase-3-test/

Merck to buy Afferent in potential $1.25 bn deal

https://pharmaphorum.com/news/merck-buy-afferent-potential-1-25-bn-deal/

Close in 10 seconds

Pharmaphorum.com

Search